Royal Bank of Canada’s HOOKIPA Pharma HOOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-28,852
| Closed | -$36K | – | 7287 |
|
|
2025
Q2 | $36K | Buy |
28,852
+6,150
| +27% | +$7.59K | ﹤0.01% | 6060 |
|
|
2025
Q1 | $25K | Buy |
22,702
+3,309
| +17% | +$5.45K | ﹤0.01% | 5834 |
|
|
2024
Q4 | $39K | Sell |
19,393
-4,237
| -18% | -$13.1K | ﹤0.01% | 5809 |
|
|
2024
Q3 | $102K | Buy |
23,630
+2,086
| +10% | +$11K | ﹤0.01% | 5330 |
|
|
2024
Q2 | $127K | Buy |
21,544
+514
| +2% | +$4.08K | ﹤0.01% | 5116 |
|
|
2024
Q1 | $150K | Sell |
21,030
-1,003
| -5% | -$7.14K | ﹤0.01% | 4925 |
|
|
2023
Q4 | $178K | Sell |
22,033
-19,964
| -48% | -$110K | ﹤0.01% | 5200 |
|
|
2023
Q3 | $259K | Buy |
41,997
+1,956
| +5% | +$14.4K | ﹤0.01% | 4570 |
|
|
2023
Q2 | $352K | Sell |
40,041
-2,237
| -5% | -$24.8K | ﹤0.01% | 4229 |
|
|
2023
Q1 | $311K | Buy |
42,278
+2,247
| +6% | +$20.1K | ﹤0.01% | 4261 |
|
|
2022
Q4 | $324K | Buy |
40,031
+10,935
| +38% | +$118K | ﹤0.01% | 4472 |
|
|
2022
Q3 | $390K | Buy |
29,096
+2,827
| +11% | +$43.4K | ﹤0.01% | 4236 |
|
|
2022
Q2 | $428K | Buy |
26,269
+681
| +3% | +$11.3K | ﹤0.01% | 4212 |
|
|
2022
Q1 | $584K | Buy |
25,588
+9,023
| +54% | +$162K | ﹤0.01% | 4157 |
|
|
2021
Q4 | $386K | Buy |
16,565
+5,926
| +56% | +$238K | ﹤0.01% | 4705 |
|
|
2021
Q3 | $626K | Buy |
10,639
+7,053
| +197% | +$511K | ﹤0.01% | 4163 |
|
|
2021
Q2 | $329K | Buy |
3,586
+2,392
| +200% | +$319K | ﹤0.01% | 4643 |
|
|
2021
Q1 | $161K | Sell |
1,194
-273
| -19% | -$32.9K | ﹤0.01% | 5109 |
|
|
2020
Q4 | $162K | Buy |
1,467
+534
| +57% | +$57.7K | ﹤0.01% | 5011 |
|
|
2020
Q3 | $88K | Buy |
933
+28
| +3% | +$2.85K | ﹤0.01% | 5043 |
|
|
2020
Q2 | $105K | Buy |
905
+80
| +10% | +$7.8K | ﹤0.01% | 4827 |
|
|
2020
Q1 | $68K | Buy |
825
+371
| +82% | +$40.6K | ﹤0.01% | 4994 |
|
|
2019
Q4 | $56K | Buy |
454
+84
| +23% | +$7.13K | ﹤0.01% | 5400 |
|
|
2019
Q3 | $28K | Buy |
370
+10
| +3% | +$738 | ﹤0.01% | 5355 |
|
|
2019
Q2 | $24K | Buy |
+360
| New | +$38.2K | ﹤0.01% | 5622 |
|
Other funds holding HOOK
KCM
JC
XT
Royal Bank of Canada's HOOK Position: Q3 2025 in Review
Royal Bank of Canada sold out of HOOKIPA Pharma (HOOK) in Q3 2025, closing a stake of 28,852 shares — an estimated $36K sold.
Royal Bank of Canada first reported a position in HOOK in Q2 2019 and held it in 25 quarters. The position peaked at $626K in Q3 2021. 6 funds tracked by Wall St. Rank hold HOOK as of Q3 2025.
- Royal Bank of Canada reported no remaining HOOKIPA Pharma position as of Q3 2025 after selling out during the quarter.
- Royal Bank of Canada sold 28,852 HOOKIPA Pharma shares in Q3 2025, an estimated $36K.
- Royal Bank of Canada first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 25 quarters.
- Royal Bank of Canada's HOOKIPA Pharma position peaked at $626K in Q3 2021.
- 6 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2025.
Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.